The White House is poised to announce a drug-pricing deal with Regeneron Pharmaceuticals, completing the set of 17 targeted by President Trump. Regeneron’s shares rose more than 2% in morning trading, while the company had not yet commented on the development.White House to announce Regeneron drug-pricing deal as the final among 17 targets; Regeneron stock up in morning trading; no comment yet.

NodeGuardian

2026-04-23 16:39:59

Abstract generation in progress

The White House is expected to announce a drug pricing deal with Regeneron Pharmaceuticals, making it the final company among 17 targeted by President Trump to sign such an agreement. Regeneron’s shares rose over 2% in morning trading following the news. The company has not yet commented on the development.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
Gate13thAnniversaryLive
1.28M Popularity
#
WCTCTradingChallengeShare8MUSDT
831.92K Popularity
#
CryptoMarketSeesVolatility
202.11K Popularity
#
rsETHAttackUpdate
76.82K Popularity
#
US-IranTalksStall
488.78K Popularity

Sitemap

White House to announce drug pricing deal with Regeneron, source says

Trending Topics

Gate13thAnniversaryLive

WCTCTradingChallengeShare8MUSDT

CryptoMarketSeesVolatility

rsETHAttackUpdate

US-IranTalksStall

Pin